首页 > 最新文献

Applied Biosafety最新文献

英文 中文
Decontamination Validation of the BSL-4 Chemical Disinfectant Deluge Shower System. BSL-4型化学消毒液雨淋系统的去污验证。
IF 0.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-16 eCollection Date: 2024-12-01 DOI: 10.1089/apb.2024.0011
Anders Leung, Todd Cutts, Jay Krishnan

Introduction: Positive pressure breathing-air-fed protective suits are used in biosafety level 4 (BSL-4) containment laboratories as personal protective equipment to protect workers from high-consequence pathogens. However, even with the use of primary containment devices, the exterior surfaces of these suits could potentially become contaminated with those pathogens and result in their inadvertent removal from containment. To address the risk of such pathogens escaping from containment via contaminated protective suits, these suits are decontaminated in a disinfectant chemical shower situated in an anteroom prior to exiting the BSL-4 laboratory. Properly diluted chemical disinfectants such as Micro-Chem Plus™ (MCP) or peracetic acid are used for this purpose. However, whether these suits are properly decontaminated during the chemical shower process needs to be validated.

Methods: The purpose of this study was to develop a suit decontamination validation method for the BSL-4 chemical showers using a risk group 2 (RG2) surrogate virus for the high consequence pathogens that are handled in the BSL-4 laboratories. Here, we evaluated the efficacy of a 5% MCP shower using coupons made from different parts of protective suits (suit fabric, visor, boot, vinyl tape) laden with a dried-on mixture of vesicular stomatitis virus in tripartite organic soil load.

Discussion: This validation study demonstrated that a chemical deluge shower procedure using 5% MCP for 2 min followed by a 3-min water rinse was successful in decontaminating the positive pressure suits that were experimentally contaminated with the live RG2 virus. This offers valuable insights into the rigor of the decontamination process being undertaken in the BSL-4 laboratory chemical showers.

简介:正压吸气式防护服用于生物安全4级(BSL-4)防护实验室,作为个人防护设备,保护工人免受高后果病原体的侵害。然而,即使使用了主要的密封装置,这些防护服的外表面也可能被这些病原体污染,并导致它们无意中从密封装置中被移除。为了解决这些病原体通过被污染的防护服从容器中逃逸的风险,这些防护服在离开BSL-4实验室之前,在接待室的消毒化学淋浴器中进行消毒。为此使用适当稀释的化学消毒剂,如Micro-Chem Plus™(MCP)或过氧乙酸。然而,这些服装是否在化学淋浴过程中得到了适当的净化需要验证。方法:本研究的目的是为在BSL-4实验室处理的高后果病原体开发一种使用风险组2 (RG2)替代病毒的BSL-4化学淋浴器套装去污验证方法。在这里,我们评估了5% MCP淋浴的效果,使用由防护服不同部分(西装面料、遮阳板、靴子、乙烯基胶带)制成的贴片,在三方有机土壤负载下,将干燥的水疱性口炎病毒混合物装入。讨论:本验证研究表明,使用5% MCP进行2分钟的化学淋浴,然后进行3分钟的水冲洗,可以成功地对实验中被活RG2病毒污染的正压服进行去污。这为在BSL-4实验室化学淋浴中进行的去污过程的严谨性提供了宝贵的见解。
{"title":"Decontamination Validation of the BSL-4 Chemical Disinfectant Deluge Shower System.","authors":"Anders Leung, Todd Cutts, Jay Krishnan","doi":"10.1089/apb.2024.0011","DOIUrl":"10.1089/apb.2024.0011","url":null,"abstract":"<p><strong>Introduction: </strong>Positive pressure breathing-air-fed protective suits are used in biosafety level 4 (BSL-4) containment laboratories as personal protective equipment to protect workers from high-consequence pathogens. However, even with the use of primary containment devices, the exterior surfaces of these suits could potentially become contaminated with those pathogens and result in their inadvertent removal from containment. To address the risk of such pathogens escaping from containment via contaminated protective suits, these suits are decontaminated in a disinfectant chemical shower situated in an anteroom prior to exiting the BSL-4 laboratory. Properly diluted chemical disinfectants such as Micro-Chem Plus™ (MCP) or peracetic acid are used for this purpose. However, whether these suits are properly decontaminated during the chemical shower process needs to be validated.</p><p><strong>Methods: </strong>The purpose of this study was to develop a suit decontamination validation method for the BSL-4 chemical showers using a risk group 2 (RG2) surrogate virus for the high consequence pathogens that are handled in the BSL-4 laboratories. Here, we evaluated the efficacy of a 5% MCP shower using coupons made from different parts of protective suits (suit fabric, visor, boot, vinyl tape) laden with a dried-on mixture of vesicular stomatitis virus in tripartite organic soil load.</p><p><strong>Discussion: </strong>This validation study demonstrated that a chemical deluge shower procedure using 5% MCP for 2 min followed by a 3-min water rinse was successful in decontaminating the positive pressure suits that were experimentally contaminated with the live RG2 virus. This offers valuable insights into the rigor of the decontamination process being undertaken in the BSL-4 laboratory chemical showers.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"29 4","pages":"241-247"},"PeriodicalIF":0.5,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence. 在人工智能时代保护邮购 DNA 合成。
IF 0.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-20 eCollection Date: 2024-06-01 DOI: 10.1089/apb.2023.0020
Stephanie Batalis, Caroline Schuerger, Gigi Kwik Gronvall, Matthew E Walsh

Introduction: Artificial intelligence (AI) tools continue to be developed and used within the life sciences. The impact of these tools on the biosecurity landscape surrounding mail-order DNA synthesis and how to address the impacts have not been critically examined in the literature.

Methods: The impacts of AI-driven chatbots and biological design tools on the biosecurity landscape surrounding mail-order DNA synthesis were analyzed and described. The findings are informed by the authors' experience in the field.

Results: Generally, chatbots lower barriers to access of information that could be misused while biological design tools may provide new abilities to users with the intent of misuse. Six recommendations to the United States Government that attempt to maximize the benefits of these new technologies while mitigating risks are provided.

Conclusion: Mandating mail-order DNA synthesis providers to screen DNA synthesis orders is a critical safeguarding step that should be taken as soon as possible. Over time, biological design tools will reduce the effectiveness of such a regulation and actions should be taken now to limit the negative impacts in the future.

导言:人工智能(AI)工具在生命科学领域不断得到开发和使用。这些工具对围绕邮购 DNA 合成的生物安全环境的影响以及如何应对这些影响,文献中还没有进行批判性研究:分析并描述了人工智能驱动的聊天机器人和生物设计工具对邮购 DNA 合成的生物安全环境的影响。结果:总体而言,聊天机器人降低了邮购 DNA 合成的门槛:一般来说,聊天机器人降低了获取可能被滥用的信息的门槛,而生物设计工具则可能为用户提供新的能力,意图造成滥用。本文向美国政府提出了六项建议,试图最大限度地利用这些新技术,同时降低风险:强制要求邮购 DNA 合成提供商对 DNA 合成订单进行筛查是一项关键的保障措施,应尽快采取。随着时间的推移,生物设计工具将降低这种法规的效力,现在就应采取行动,限制未来的负面影响。
{"title":"Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence.","authors":"Stephanie Batalis, Caroline Schuerger, Gigi Kwik Gronvall, Matthew E Walsh","doi":"10.1089/apb.2023.0020","DOIUrl":"10.1089/apb.2023.0020","url":null,"abstract":"<p><strong>Introduction: </strong>Artificial intelligence (AI) tools continue to be developed and used within the life sciences. The impact of these tools on the biosecurity landscape surrounding mail-order DNA synthesis and how to address the impacts have not been critically examined in the literature.</p><p><strong>Methods: </strong>The impacts of AI-driven chatbots and biological design tools on the biosecurity landscape surrounding mail-order DNA synthesis were analyzed and described. The findings are informed by the authors' experience in the field.</p><p><strong>Results: </strong>Generally, chatbots lower barriers to access of information that could be misused while biological design tools may provide new abilities to users with the intent of misuse. Six recommendations to the United States Government that attempt to maximize the benefits of these new technologies while mitigating risks are provided.</p><p><strong>Conclusion: </strong>Mandating mail-order DNA synthesis providers to screen DNA synthesis orders is a critical safeguarding step that should be taken as soon as possible. Over time, biological design tools will reduce the effectiveness of such a regulation and actions should be taken now to limit the negative impacts in the future.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"29 2","pages":"79-84"},"PeriodicalIF":0.5,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11313546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141915971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call for Volume 30 (2025) Special Issue Papers: Biosafety and Biosecurity for Potential Pandemic Pathogens and Dual-Use Research of Concern: Deadline for Manuscript Submission: October 31, 2024. 征集第 30 卷(2025 年)特刊论文:潜在流行病病原体和两用研究的生物安全和生物安保:投稿截止日期:2024 年 10 月 31 日:投稿截止日期:2024 年 10 月 31 日。
IF 0.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-20 eCollection Date: 2024-06-01 DOI: 10.1089/apb.2024.48276.cfp
George Poste, Filippa Lentzos, Barbara Johnson, David R Gillum
{"title":"<i>Call for Volume 30 (2025) Special Issue Papers:</i> Biosafety and Biosecurity for Potential Pandemic Pathogens and Dual-Use Research of Concern: Deadline for Manuscript Submission: October 31, 2024.","authors":"George Poste, Filippa Lentzos, Barbara Johnson, David R Gillum","doi":"10.1089/apb.2024.48276.cfp","DOIUrl":"https://doi.org/10.1089/apb.2024.48276.cfp","url":null,"abstract":"","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"29 2","pages":"59-60"},"PeriodicalIF":0.5,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11313547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141915970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of Leaks from Conical Centrifuge Tubes 锥形离心管泄漏频率
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-22 DOI: 10.1089/apb.2023.0013
Henry Wyneken, Kelly N. Kim, Audrey A. Cerles, Christine Heren, Sydney Bowman, Emma J. Reuter, Colin McCarty, Kaylin Chen, Sean CJ Daly, Lauren Gherman, Iqra Imran, Jenna Marcopul, Alannah Miller, Andrea Valladares, Caitlin Wrinn, A. E. Fleming, Rebecca Roberts, Rocco Casagrande
{"title":"Frequency of Leaks from Conical Centrifuge Tubes","authors":"Henry Wyneken, Kelly N. Kim, Audrey A. Cerles, Christine Heren, Sydney Bowman, Emma J. Reuter, Colin McCarty, Kaylin Chen, Sean CJ Daly, Lauren Gherman, Iqra Imran, Jenna Marcopul, Alannah Miller, Andrea Valladares, Caitlin Wrinn, A. E. Fleming, Rebecca Roberts, Rocco Casagrande","doi":"10.1089/apb.2023.0013","DOIUrl":"https://doi.org/10.1089/apb.2023.0013","url":null,"abstract":"","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"293 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139247519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Boundary Integrity Testing of Containment Level 3 (Biological Safety Level 3) Laboratories 安全壳3级(生物安全3级)实验室边界完整性测试
Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-14 DOI: 10.1089/apb.2023.0017
Cory Ziegler, Gilles Tremblay
Background: Containment Level 3 (CL3) laboratories may require boundary integrity testing. Existing guidelines for CL3 room leakage are often subjective, lacking a definitive standard for what constitutes a “sealed” room. Methods: This study reviews global biocontainment guidelines and standards, and it compares multiple test results from global CL3 facilities by standardizing test data to an equivalent test pressure of 250 Pa. Results: Our analysis revealed that 55% of rooms constructed using typical CL3 methodologies met the proposed testing criteria. The United States Department of Agriculture (USDA) Agricultural Research Service (ARS) greenhouse leakage rate acceptance criterion of 0.139 L/s per square meter (0.027 cfm per square foot) at a room differential pressure of 250 Pa was found to be a challenging, yet achievable standard. Conclusions: A two-step process is recommended for boundary integrity testing: (1) Initial leaks are identified using smoke pencil or soap bubble tests, followed by necessary repairs; (2) The room is then subjected to quantifiable leakage rate testing to verify it meets minimum requirements. In the absence of definitive local guidelines, we recommend the published ARS greenhouse leakage rate at a room differential pressure of 300 Pa of 0.152 L/s per square meter of surface area as an acceptable criterion for testing construction boundaries of CL3 laboratories built using current CL3 construction practices. For primary containment CL3 rooms, a more stringent criterion following the German Verein Deutscher Ingenieure guidelines at a room pressure differential of 250 Pa is noted as 0.03620 L/s per square meter of room surface area is more appropriate.
背景:3级(CL3)实验室可能需要进行边界完整性测试。现有的CL3房间泄漏指南往往是主观的,缺乏一个确定的标准,什么是“密封”的房间。方法:本研究回顾了全球生物防护指南和标准,并通过将测试数据标准化到250 Pa的等效测试压力,比较了全球CL3设施的多次测试结果。结果:我们的分析显示,55%使用典型CL3方法建造的房间符合提议的测试标准。美国农业部(USDA)农业研究服务局(ARS)温室气体泄漏率验收标准为每平方米0.139升/秒(0.027立方英尺/平方英尺),房间压差为250 Pa,这是一个具有挑战性的,但可以实现的标准。结论:边界完整性测试建议采用两步流程:(1)使用烟笔或肥皂泡测试确定初始泄漏,然后进行必要的修复;(2)然后对房间进行可量化的泄漏率测试,以验证其满足最低要求。在缺乏明确的地方指导方针的情况下,我们建议将已公布的ARS温室泄漏率作为使用当前CL3建筑实践建造的CL3实验室的建筑边界测试的可接受标准。房间压差为300 Pa,每平方米表面积0.152升/秒。对于主密封CL3房间,在房间压差为250 Pa时,遵循德国协会德国工程师协会指南的更严格的标准被认为是每平方米房间表面积0.03620 L/s更合适。
{"title":"Boundary Integrity Testing of Containment Level 3 (Biological Safety Level 3) Laboratories","authors":"Cory Ziegler, Gilles Tremblay","doi":"10.1089/apb.2023.0017","DOIUrl":"https://doi.org/10.1089/apb.2023.0017","url":null,"abstract":"Background: Containment Level 3 (CL3) laboratories may require boundary integrity testing. Existing guidelines for CL3 room leakage are often subjective, lacking a definitive standard for what constitutes a “sealed” room. Methods: This study reviews global biocontainment guidelines and standards, and it compares multiple test results from global CL3 facilities by standardizing test data to an equivalent test pressure of 250 Pa. Results: Our analysis revealed that 55% of rooms constructed using typical CL3 methodologies met the proposed testing criteria. The United States Department of Agriculture (USDA) Agricultural Research Service (ARS) greenhouse leakage rate acceptance criterion of 0.139 L/s per square meter (0.027 cfm per square foot) at a room differential pressure of 250 Pa was found to be a challenging, yet achievable standard. Conclusions: A two-step process is recommended for boundary integrity testing: (1) Initial leaks are identified using smoke pencil or soap bubble tests, followed by necessary repairs; (2) The room is then subjected to quantifiable leakage rate testing to verify it meets minimum requirements. In the absence of definitive local guidelines, we recommend the published ARS greenhouse leakage rate at a room differential pressure of 300 Pa of 0.152 L/s per square meter of surface area as an acceptable criterion for testing construction boundaries of CL3 laboratories built using current CL3 construction practices. For primary containment CL3 rooms, a more stringent criterion following the German Verein Deutscher Ingenieure guidelines at a room pressure differential of 250 Pa is noted as 0.03620 L/s per square meter of room surface area is more appropriate.","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"8 8","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136229562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Importance and Challenges of Implementing and Maintaining Biorepositories for High-Consequence Veterinary and One Health Pathogens in South-East Asia 东南亚实施和维护高后果兽医和单一卫生病原体生物储存库的重要性和挑战
Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-10-23 DOI: 10.1089/apb.2023.0006
Malinee Oyuchua, Jarunee Siengsanan-Lamont, Kim Khanh Le, Somjai Kamolsiripichaiporn, Jeeranan Areerob, Pacharee Thongkamkoon, Watthana Theppangna, Phouvong Phommachanh, Sothyra Tum, Barbara Johnson, Stuart D. Blacksell
Introduction: Emerging infectious diseases pose a threat to public health and the economy, especially in developing countries. Southeast Asian veterinary laboratories handle numerous high-risk pathogens, making pathogen accountability crucial for safe handling and storage. Methods: Thirteen veterinary laboratories in Cambodia (n = 1), Lao People's Democratic Republic (n = 1), and Thailand (n = 11) participated in a study conducted between 2019 and 2020. Data were collected using a questionnaire, group discussions, and interviews. Conclusion: Significant gaps in biosecurity and biorepository management were recognized and discussed in the context of regional biosafety and biosecurity. Laboratories could use the findings and recommendations of the study to develop or improve their pathogen inventory and biosecurity systems. Governments play a significant role in setting standards and regulations and providing necessary support for laboratories to maintain inventory controls sustainably and have a very important role to play in ensuring biosafety and biosecurity compliance.
新出现的传染病对公共卫生和经济构成威胁,特别是在发展中国家。东南亚兽医实验室处理大量高风险病原体,因此病原体问责制对安全处理和储存至关重要。方法:2019 - 2020年,柬埔寨(n = 1)、老挝人民民主共和国(n = 1)和泰国(n = 11)的13个兽医实验室参与了研究。通过问卷调查、小组讨论和访谈收集数据。结论:在区域生物安全和生物安全的背景下,认识并讨论了生物安全和生物库管理方面的重大差距。实验室可以利用这项研究的发现和建议来发展或改进其病原体清单和生物安全系统。政府在制定标准和条例以及为实验室提供必要支持以可持续地维持库存控制方面发挥重要作用,并在确保生物安全和遵守生物安全方面发挥非常重要的作用。
{"title":"The Importance and Challenges of Implementing and Maintaining Biorepositories for High-Consequence Veterinary and One Health Pathogens in South-East Asia","authors":"Malinee Oyuchua, Jarunee Siengsanan-Lamont, Kim Khanh Le, Somjai Kamolsiripichaiporn, Jeeranan Areerob, Pacharee Thongkamkoon, Watthana Theppangna, Phouvong Phommachanh, Sothyra Tum, Barbara Johnson, Stuart D. Blacksell","doi":"10.1089/apb.2023.0006","DOIUrl":"https://doi.org/10.1089/apb.2023.0006","url":null,"abstract":"Introduction: Emerging infectious diseases pose a threat to public health and the economy, especially in developing countries. Southeast Asian veterinary laboratories handle numerous high-risk pathogens, making pathogen accountability crucial for safe handling and storage. Methods: Thirteen veterinary laboratories in Cambodia (n = 1), Lao People's Democratic Republic (n = 1), and Thailand (n = 11) participated in a study conducted between 2019 and 2020. Data were collected using a questionnaire, group discussions, and interviews. Conclusion: Significant gaps in biosecurity and biorepository management were recognized and discussed in the context of regional biosafety and biosecurity. Laboratories could use the findings and recommendations of the study to develop or improve their pathogen inventory and biosecurity systems. Governments play a significant role in setting standards and regulations and providing necessary support for laboratories to maintain inventory controls sustainably and have a very important role to play in ensuring biosafety and biosecurity compliance.","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"2002 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135412665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical Considerations for Navigating Withdrawal from the Federal Select Agent Program 退出联邦特工选拔计划的实际考虑
Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-10-19 DOI: 10.1089/apb.2023.0014
Scott J. Patlovich, Kristin G. King, Robert J. Emery, Zackary B. Becker, Rebecca B. Kairis
Introduction: Clear guidance is provided by the Federal Select Agent Program (FSAP) to assist registered entities in nearly all facets of compliance with the Federal select agent regulations (7 CFR Part 331; 9 CFR Part 121; 42 CFR Part 73). If a registered entity chooses to discontinue its registration, detailed instructions for registration withdrawal are deeply embedded within a document entitled “eFSAP Form 1 Amendment Instructions,” which is found on the FSAP website within the electronic Federal Select Agent Program (eFSAP) Resource Center. Methods: Using the information found within the eFSAP Form 1 Amendment Instructions, as well as extensive written and verbal guidance provided by the lead assigned entity point of contact at the FSAP, we completed the FSAP withdrawal process during a 12-month period between 2022 and 2023. Discussion: This commentary shares our recent professional experiences navigating the FSAP withdrawal process at the University of Texas Health Science Center at Houston (UTHealth Houston). Successes, challenges, and lessons learned are shared so that others planning or considering withdrawing may benefit from our experience. Conclusion: The resources provided for withdrawal within the eFSAP Form 1 Amendment Instructions are relatively basic, and additional details are not currently found in other FSAP guidance documents. Therefore, direct communication and support from the FSAP to the entity Responsible Officials are imperative to ensure a safe, secure, and compliant withdrawal.
简介:联邦特工计划(FSAP)提供了明确的指导,以帮助注册实体在几乎所有方面遵守联邦特工条例(7 CFR Part 331;9 CFR第121部分;42 CFR第73部分)。如果已注册实体选择终止其注册,则在FSAP网站的电子联邦特工计划(eFSAP)资源中心内,可以找到题为“eFSAP表格1修改说明”的文件中详细说明撤销注册。方法:使用eFSAP表格1修订说明中的信息,以及由FSAP指定的主要实体联络点提供的广泛的书面和口头指导,我们在2022年至2023年的12个月期间完成了FSAP撤销流程。讨论:这篇评论分享了我们最近在休斯顿德克萨斯大学健康科学中心(UTHealth Houston)指导FSAP退出过程的专业经验。我们分享成功、挑战和经验教训,以便其他计划或考虑退出的人可以从我们的经验中受益。结论:eFSAP表格1修订说明中提供的退出资源相对基本,目前在其他FSAP指导文件中没有找到额外的细节。因此,FSAP与实体责任官员的直接沟通和支持是确保安全、可靠和合规退出的必要条件。
{"title":"Practical Considerations for Navigating Withdrawal from the Federal Select Agent Program","authors":"Scott J. Patlovich, Kristin G. King, Robert J. Emery, Zackary B. Becker, Rebecca B. Kairis","doi":"10.1089/apb.2023.0014","DOIUrl":"https://doi.org/10.1089/apb.2023.0014","url":null,"abstract":"Introduction: Clear guidance is provided by the Federal Select Agent Program (FSAP) to assist registered entities in nearly all facets of compliance with the Federal select agent regulations (7 CFR Part 331; 9 CFR Part 121; 42 CFR Part 73). If a registered entity chooses to discontinue its registration, detailed instructions for registration withdrawal are deeply embedded within a document entitled “eFSAP Form 1 Amendment Instructions,” which is found on the FSAP website within the electronic Federal Select Agent Program (eFSAP) Resource Center. Methods: Using the information found within the eFSAP Form 1 Amendment Instructions, as well as extensive written and verbal guidance provided by the lead assigned entity point of contact at the FSAP, we completed the FSAP withdrawal process during a 12-month period between 2022 and 2023. Discussion: This commentary shares our recent professional experiences navigating the FSAP withdrawal process at the University of Texas Health Science Center at Houston (UTHealth Houston). Successes, challenges, and lessons learned are shared so that others planning or considering withdrawing may benefit from our experience. Conclusion: The resources provided for withdrawal within the eFSAP Form 1 Amendment Instructions are relatively basic, and additional details are not currently found in other FSAP guidance documents. Therefore, direct communication and support from the FSAP to the entity Responsible Officials are imperative to ensure a safe, secure, and compliant withdrawal.","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135729062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Brazilian High- and Maximum-Containment Laboratories Biosafety and Biosecurity Regulations to Legal Frameworks in the United States and Other Countries: Gaps and Opportunities 巴西高隔离和最高隔离实验室生物安全和生物安保条例与美国和其他国家法律框架的比较:差距和机遇
Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-09-13 DOI: 10.1089/apb.2023.0005
André de Oliveira Mendonça, Kurt Allen Zuelke, Melissa M. Kahl-Mcdonagh, Claudio Mafra
Introduction: Although the United States and other countries have implemented comprehensive legislation, regulations, and policies to support biosafety and biosecurity of high- and maximum-containment laboratories, Brazil's legislation has notable gaps and inconsistencies. Objective: To evaluate the Brazilian approach to ensuring nationwide biosafety and biosecurity oversight and governance of high- and maximum-containment laboratories. Methods: A systematic gap analysis was conducted to compare Brazilian biosafety and biosecurity legislation, regulations, and policies with their international counterparts, with a particular focus on the oversight and governance of high- and maximum-containment laboratories. Results: We found that Brazilian biosafety and biosecurity legislation, regulations, and policies have relevant gaps. Governance and regulatory oversight of Brazil's high- and maximum-containment laboratories are decentralized with variable levels of adherence to commonly accepted global biosafety and biosecurity compliance standards. These findings represent a limitation not only to governance but also to the preparedness to face current and future challenges related to emergent infectious diseases in Brazil. Enhancing the Brazilian legal framework on laboratory biosafety and biosecurity is necessary and urgent. Reviewing the lessons learned and regulations applied in the United States and other international frameworks helped identify potential areas for improving Brazil's ability to inventory and manage its diverse biocontainment laboratory capabilities and assure these valuable resources align with national needs and priorities. Conclusion: The Brazilian government has an opportunity to revise and improve upon a national set of legislation, regulations, and policies for its high- and maximum-containment laboratories, taking advantage of legislation and guidelines published by other countries.
导言:尽管美国和其他国家已经实施了全面的立法、法规和政策,以支持高度和最高限度控制实验室的生物安全和生物安全,但巴西的立法存在明显的差距和不一致之处。目的:评估巴西在确保全国生物安全和生物安全监督以及对高隔离和最高隔离实验室进行治理方面的做法。方法:进行了系统的差距分析,将巴西的生物安全和生物安全立法、法规和政策与国际同行进行比较,特别侧重于对高密封和最高密封实验室的监督和治理。结果:我们发现巴西生物安全和生物安全立法、法规和政策存在相关差距。巴西高隔离和最高隔离实验室的治理和监管是分散的,遵守普遍接受的全球生物安全和生物安全合规标准的程度各不相同。这些发现不仅表明在治理方面存在局限性,而且表明在巴西应对与突发传染病有关的当前和未来挑战的准备方面存在局限性。加强巴西实验室生物安全和生物安保的法律框架是必要和紧迫的。审查在美国和其他国际框架中吸取的经验教训和适用的法规,有助于确定提高巴西盘点和管理其多样化生物控制实验室能力的能力的潜在领域,并确保这些宝贵资源符合国家需要和优先事项。结论:巴西政府有机会利用其他国家公布的立法和指导方针,修订和完善一套针对其高和最高遏制实验室的国家立法、法规和政策。
{"title":"Comparison of Brazilian High- and Maximum-Containment Laboratories Biosafety and Biosecurity Regulations to Legal Frameworks in the United States and Other Countries: Gaps and Opportunities","authors":"André de Oliveira Mendonça, Kurt Allen Zuelke, Melissa M. Kahl-Mcdonagh, Claudio Mafra","doi":"10.1089/apb.2023.0005","DOIUrl":"https://doi.org/10.1089/apb.2023.0005","url":null,"abstract":"Introduction: Although the United States and other countries have implemented comprehensive legislation, regulations, and policies to support biosafety and biosecurity of high- and maximum-containment laboratories, Brazil's legislation has notable gaps and inconsistencies. Objective: To evaluate the Brazilian approach to ensuring nationwide biosafety and biosecurity oversight and governance of high- and maximum-containment laboratories. Methods: A systematic gap analysis was conducted to compare Brazilian biosafety and biosecurity legislation, regulations, and policies with their international counterparts, with a particular focus on the oversight and governance of high- and maximum-containment laboratories. Results: We found that Brazilian biosafety and biosecurity legislation, regulations, and policies have relevant gaps. Governance and regulatory oversight of Brazil's high- and maximum-containment laboratories are decentralized with variable levels of adherence to commonly accepted global biosafety and biosecurity compliance standards. These findings represent a limitation not only to governance but also to the preparedness to face current and future challenges related to emergent infectious diseases in Brazil. Enhancing the Brazilian legal framework on laboratory biosafety and biosecurity is necessary and urgent. Reviewing the lessons learned and regulations applied in the United States and other international frameworks helped identify potential areas for improving Brazil's ability to inventory and manage its diverse biocontainment laboratory capabilities and assure these valuable resources align with national needs and priorities. Conclusion: The Brazilian government has an opportunity to revise and improve upon a national set of legislation, regulations, and policies for its high- and maximum-containment laboratories, taking advantage of legislation and guidelines published by other countries.","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"9 10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135781253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Industry Proposal for a Cell and Gene Therapy Safety Data Sheet. 细胞和基因治疗安全性数据表的行业提案。
IF 0.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-09-01 Epub Date: 2023-09-12 DOI: 10.1089/apb.2023.0009
Qirong Wu, Shana Elkind, Francine Preston, Michael Wachala, Erin Dunn, Sarah K White, Dirk Windhorst, Kimberly DiGiandomenico, Colin McGuire, Herbert Brok, Rachel Hodges

Introduction: A safety data sheet (SDS) is an established hazard communication tool for chemicals, for which no comparable document exists in the biotherapeutics industry. As the cell and gene therapy (CGT) field expands, industry leaders have identified a growing need to address this gap in communication of the unique occupational health and safety risks posed by CGT materials and products.

Methods: Following the sections of a traditional chemical SDS, information was modified by industry subject matter experts, relevant to CGT biological materials. This guide was developed based on assumptions of a maximum biosafety level 2, and any chemical components present in the material were excluded from the hazard classification.

Results: The guide contains necessary information to conduct a workplace risk assessment and communicate the unique workplace hazards posed by potential exposures to the material. The target audience is intended to be entities handling and producing these materials, plus collaborators, contractors, or operations sites receiving and handling the CGT material. An example of a CGT SDS is provided in Table 1.

Discussion: The CGT SDS provides industry with a best practice to address an existing gap in hazard communication for CGT. We expect that, as the field evolves, so may the contents. The CGT SDS can be used as a reference for other biological modalities in the field.

Conclusions: This initial CGT SDS communicates workplace hazards and assesses the unique risks posed by these biological materials and can assist in creating exposure control plans specific to the workplace hazards.

简介:安全数据表(SDS)是一种已建立的化学品危害沟通工具,生物治疗行业中没有类似的文件。随着细胞和基因治疗(CGT)领域的扩展,行业领导者已经发现,在沟通CGT材料和产品带来的独特职业健康和安全风险方面,越来越需要解决这一差距。方法:根据传统化学SDS的章节,由行业主题专家对与CGT生物材料相关的信息进行修改。本指南是根据最高生物安全等级2的假设制定的,材料中存在的任何化学成分都被排除在危险分类之外。结果:该指南包含了进行工作场所风险评估的必要信息,并传达了潜在接触该材料所造成的独特工作场所危害。目标受众是处理和生产这些材料的实体,以及接收和处理CGT材料的合作者、承包商或运营现场。表1中提供了CGT SDS的一个示例。讨论:CGT SDS为行业提供了最佳实践,以解决CGT危险沟通方面的现有差距。我们预计,随着该领域的发展,内容也可能会有所不同。CGT SDS可作为该领域其他生物学模式的参考。结论:该初始CGT SDS传达了工作场所的危害,并评估了这些生物材料带来的独特风险,可以帮助制定针对工作场所危害的暴露控制计划。
{"title":"An Industry Proposal for a Cell and Gene Therapy Safety Data Sheet.","authors":"Qirong Wu, Shana Elkind, Francine Preston, Michael Wachala, Erin Dunn, Sarah K White, Dirk Windhorst, Kimberly DiGiandomenico, Colin McGuire, Herbert Brok, Rachel Hodges","doi":"10.1089/apb.2023.0009","DOIUrl":"10.1089/apb.2023.0009","url":null,"abstract":"<p><strong>Introduction: </strong>A safety data sheet (SDS) is an established hazard communication tool for chemicals, for which no comparable document exists in the biotherapeutics industry. As the cell and gene therapy (CGT) field expands, industry leaders have identified a growing need to address this gap in communication of the unique occupational health and safety risks posed by CGT materials and products.</p><p><strong>Methods: </strong>Following the sections of a traditional chemical SDS, information was modified by industry subject matter experts, relevant to CGT biological materials. This guide was developed based on assumptions of a maximum biosafety level 2, and any chemical components present in the material were excluded from the hazard classification.</p><p><strong>Results: </strong>The guide contains necessary information to conduct a workplace risk assessment and communicate the unique workplace hazards posed by potential exposures to the material. The target audience is intended to be entities handling and producing these materials, plus collaborators, contractors, or operations sites receiving and handling the CGT material. An example of a CGT SDS is provided in Table 1.</p><p><strong>Discussion: </strong>The CGT SDS provides industry with a best practice to address an existing gap in hazard communication for CGT. We expect that, as the field evolves, so may the contents. The CGT SDS can be used as a reference for other biological modalities in the field.</p><p><strong>Conclusions: </strong>This initial CGT SDS communicates workplace hazards and assesses the unique risks posed by these biological materials and can assist in creating exposure control plans specific to the workplace hazards.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"28 3","pages":"176-191"},"PeriodicalIF":0.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41094684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Mpox/Monkeypox Virus. 生物安全研究路线图:寻找支持实验室实践的证据-Mpox/猴痘病毒。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-09-01 Epub Date: 2023-09-12 DOI: 10.1089/apb.2022.0045
Stuart D Blacksell, Sandhya Dhawan, Marina Kusumoto, Kim Khanh Le, Kathrin Summermatter, Joseph O'Keefe, Joseph Kozlovac, Salama Suhail Al Muhairi, Indrawati Sendow, Christina M Scheel, Anthony Ahumibe, Zibusiso M Masuku, Allan M Bennett, Kazunobu Kojima, David R Harper, Keith Hamilton

Introduction: The virus formerly known as monkeypox virus, now called mpoxv, belongs to the Orthopoxvirus genus and can cause mpox disease through both animal-to-human and human-to-human transmission. The unexpected spread of mpoxv among humans has prompted the World Health Organization (WHO) to declare a Public Health Emergency of International Concern (PHEIC).

Methods: We conducted a literature search to identify the gaps in biosafety, focusing on five main areas: how the infection enters the body and spreads, how much of the virus is needed to cause infection, infections acquired in the lab, accidental release of the virus, and strategies for disinfecting and decontaminating the area.

Discussion: The recent PHEIC has shown that there are gaps in our knowledge of biosafety when it comes to mpoxv. We need to better understand where this virus might be found, how much of it can spread from person-to-person, what are the effective control measures, and how to safely clean up contaminated areas. By gathering more biosafety evidence, we can make better decisions to protect people from this zoonotic agent, which has recently become more common in the human population.

简介:这种病毒以前被称为猴痘病毒,现在被称为mpoxv,属于正痘病毒属,可以通过动物对人和人对人的传播引起猴痘病。mpoxv在人类中的意外传播促使世界卫生组织(世界卫生组织)宣布进入国际关注的突发公共卫生事件(PHEIC),病毒的意外释放,以及消毒和净化该地区的策略。讨论:最近的PHEIC表明,在mpoxv方面,我们对生物安全的认识存在差距。我们需要更好地了解这种病毒可能在哪里发现,有多少病毒可以在人与人之间传播,有什么有效的控制措施,以及如何安全地清理污染区域。通过收集更多的生物安全证据,我们可以做出更好的决定来保护人们免受这种人畜共患病原体的侵害,这种病原体最近在人类中越来越常见。
{"title":"The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Mpox/Monkeypox Virus.","authors":"Stuart D Blacksell, Sandhya Dhawan, Marina Kusumoto, Kim Khanh Le, Kathrin Summermatter, Joseph O'Keefe, Joseph Kozlovac, Salama Suhail Al Muhairi, Indrawati Sendow, Christina M Scheel, Anthony Ahumibe, Zibusiso M Masuku, Allan M Bennett, Kazunobu Kojima, David R Harper, Keith Hamilton","doi":"10.1089/apb.2022.0045","DOIUrl":"10.1089/apb.2022.0045","url":null,"abstract":"<p><strong>Introduction: </strong>The virus formerly known as monkeypox virus, now called mpoxv, belongs to the Orthopoxvirus genus and can cause mpox disease through both animal-to-human and human-to-human transmission. The unexpected spread of mpoxv among humans has prompted the World Health Organization (WHO) to declare a Public Health Emergency of International Concern (PHEIC).</p><p><strong>Methods: </strong>We conducted a literature search to identify the gaps in biosafety, focusing on five main areas: how the infection enters the body and spreads, how much of the virus is needed to cause infection, infections acquired in the lab, accidental release of the virus, and strategies for disinfecting and decontaminating the area.</p><p><strong>Discussion: </strong>The recent PHEIC has shown that there are gaps in our knowledge of biosafety when it comes to mpoxv. We need to better understand where this virus might be found, how much of it can spread from person-to-person, what are the effective control measures, and how to safely clean up contaminated areas. By gathering more biosafety evidence, we can make better decisions to protect people from this zoonotic agent, which has recently become more common in the human population.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"28 3","pages":"152-161"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Applied Biosafety
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1